Search the Newsreel

Dekon Food and Agriculture Group Posts Higher Hog Prices, Softer Poultry Margins in July

Earnings call transcript: Poly Medicure beats Q1 2026 estimates, shares rise 4.6%

Exicure Inc (XCUR) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Exicure Inc (XCUR), focusing on future EPS and revenue growth estimates. It includes current stock information such as share price, market cap, and daily performance. The page also features a peer comparison table with ratings and analyst …

Wide Open Agriculture Signs Lupin Contract Manufacturing Framework with Proeon

SeaStar Medical Holding Corp (ICU) Earnings Forecast: Future EPS & Revenue Growth Estimates

SeaStar Medical Holding Corp (ICU) has an earnings forecast score of 8.00, placing it 65th in the Healthcare Equipment & Supplies industry. Analysts have a consensus "Buy" rating for ICU with an average price target of $1.00. The company's expected revenue for the next …

ICU Medical (ICUI) Stock Gets Fair Value Boost After Analysts Lift Targets

ICU Medical (ICUI) has seen its analyst fair value increase from US$172.50 to US$191.50 due to positive analyst revisions and target hikes. Analysts cite improving margins, progress on free cash flow, and strong execution as reasons for their bullish outlook, with some firms raising …

ICU Medical (NASDAQ:ICUI) Releases Earnings Results, Beats Expectations By $0.46 EPS

Discipline and Rules-Based Execution in ATRC Response

This article analyzes Atricure Inc. (NASDAQ: ATRC), highlighting strong near and mid-term sentiment but a weak long-term outlook. It provides AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels. The analysis also includes multi-timeframe signal analysis, showing support and …

Results: ICU Medical, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts

ICU Medical, Inc. recently reported its latest quarterly earnings, surpassing analyst expectations. Following these positive results, analysts have updated their financial forecasts for the company, indicating a potential shift in their outlook. Investors will be keen to see how these revised expectations might impact …

Atlanticus Holdings (ATLC) Stock Pullback Follows Strong Growth And Insider Selling

Atlanticus Holdings (ATLC) experienced an 11% stock drop despite reporting strong Q2 2026 earnings with revenue up 83% and net income up 67%. The pullback is attributed to a reset in investor expectations, concerns about durability and balance sheet strength, and recent insider selling. …

Atlanticus Holdings Corp (ATLC) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Atlanticus Holdings Corp (ATLC), detailing its current earnings forecast score, average price target, and analyst ratings. It highlights an average price target of $87.50 with a "Buy" trend from 6 analysts. Key financial expectations include an anticipated …

Reinhart Partners LLC. Invests $46.15 Million in ICU Medical, Inc. $ICUI

Reinhart Partners LLC. has invested $46.15 million in ICU Medical, Inc., acquiring 314,768 shares during the second quarter, making them a significant institutional holder. This investment comes as ICU Medical reported strong second-quarter earnings, beating analyst expectations and raising its fiscal 2026 EPS guidance. …

Atlanticus Holdings Corporation (NASDAQ:ATLC) Receives Average Recommendation of "Moderate Buy" from Analysts

Analysts have given Atlanticus Holdings Corporation (NASDAQ:ATLC) an average "Moderate Buy" rating, with five analysts recommending a buy, one a strong buy, and two a hold. The average 12-month price target is set at $126, exceeding the stock's opening price of $100.01. The company …

Wall Street Zen Upgrades ICU Medical (NASDAQ:ICUI) to Strong-Buy

Wall Street Zen has upgraded ICU Medical (NASDAQ:ICUI) to a "strong-buy" rating, reflecting generally positive analyst sentiment and recent strong financial performance. The company exceeded quarterly expectations with EPS of $2.37 and revenue of $547.9 million, and it provided optimistic fiscal 2026 EPS guidance. …

Two AtriCure Directors Trimmed Shares After a Strong Quarter. Here's What Matters for Investors

Two AtriCure directors, including Maggie Yuen, sold shares after a strong second quarter where the company reported 13% revenue growth and raised its full-year outlook. Yuen sold 3,500 shares, reducing her direct equity stake by 20%, though the timing of sales by multiple directors …

Raymond James raises ICU Medical stock price target on revenue growth

ICU Medical, Inc. Stock 12‑Month Price Target Raised to $194.14, Implies 17% Upside

Seven analysts have raised the average 12-month price target for ICU Medical, Inc. (ICUI) stock from $176.43 to $194.14, with individual forecasts ranging from $187 to $200 per share. This new target suggests a potential upside of approximately 17% based on the August 6th …

AtriCure Inc (ATRC) Stock News Today

This article provides the latest stock news for AtriCure Inc (ATRC), detailing its current stock price, market capitalization, and performance metrics. It also highlights that more news, earnings, analyst ratings, and key developments will be available soon.

Exicure Inc (XCUR) Stock News Today

This page provides an overview of Exicure Inc (XCUR) stock, including its current price, market cap, and a note that more news is coming soon. The stock closed at $1.345, down 0.74% on August 7th. It also lists various financial and analytical tools available …

ICU Medical (ICUI) Stock Climbs As Margin Gains Sharpen The Debate

AtriCure (ATRC) director Maggie Yuen reports sale of 3,500 shares

AtriCure director Maggie Yuen sold 3,500 shares of Common Stock on August 5, 2026, at a weighted average price of $38.42 per share, totaling approximately $134,470. The shares were sold in multiple trades ranging from $38.37 to $38.43, and she now directly holds 14,015 …

AtriCure Inc (ATRC) Director Karen Prange Sells 3,564 Shares

AtriCure Inc (ATRC) Director Karen Prange sold 3,564 shares of the company on August 5, 2026, for a total value of approximately $138,283. This sale contributes to a pattern of 14 insider sells and no buys over the past year. The stock is currently …

Price to earnings forward of Medicus Pharma Ltd. – NASDAQ:MDCX

Atlanticus Holdings (ATLC) Following Q2 Earnings, Is The Bullish Fair Value Story Still Intact?

ICU Medical, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:ICUI) 2026-08-07

ICU Medical, Inc. (ICUI) published its Q2 2026 earnings call presentation on August 7, 2026. The company reported an EPS of $2.37, beating estimates by $0.46, and revenue of $547.88 million, exceeding expectations by $13.94 million despite a slight year-over-year decrease. This article was …

ICU MEDICAL, INC. : PIPER SANDLER RAISES TARGET PRICE TO $195 FROM $163

Piper Sandler has increased its target price for ICU Medical, Inc. (ICUI.O) to $195 from $163. This update was reported by Reuters on August 7, 2026. The article itself is a brief announcement of this change.

Federal Agricultural Mortgage (AGM) Could Be 59% Overvalued As Strong Earnings Lift Sentiment

Are Business Services Stocks Lagging Cricut (CRCT) This Year?

For those looking to find strong Business Services stocks, it is prudent to search for companies in the group that are outperforming their peers. Cricut, Inc. (CRCT) is a stock that can certainly grab the attention of many investors, but do its recent returns …

Director At AtriCure Sells $134K Of Stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's stock for a total of $134,470, as reported in an SEC filing on August 7. The company's shares were trading up 2.89% at $39.49 following the report. AtriCure demonstrated strong revenue growth of 12.83% …

Atlanticus (NASDAQ:ATLC) Sees Strong Trading Volume Following Strong Earnings

Icu Medical stock hits 52-week high at 182.35 USD

ICU Medical (ICUI) stock reached a new 52-week high of $182.35, driven by positive market sentiment and strong financial performance. The company exceeded Q2 earnings and revenue expectations and raised its full-year EPS guidance, further boosted by an analyst upgrade to a $200 price …

AtriCure director Maggie Yuen sells $134,470 in stock

AtriCure Director Maggie Yuen sold 3,500 shares of the company's common stock for $134,470 on August 5, 2026. This transaction leaves Yuen with 14,015 shares. The sale occurred while AtriCure's stock is trading near its 52-week high, despite the company recently surpassing Q2 2026 …

AtriCure, Inc. (ATRC) director sells 3,564 shares at $38.80

AtriCure, Inc. director Karen Prange sold 3,564 shares of common stock at $38.80 per share on August 5, 2026, in an open market or private transaction. Following this sale, Prange directly holds 22,809 shares of AtriCure. The transaction was reported in a Form 4 …

Azioni Generali Q2: quanto valgono davvero buyback e raccolta Vita record?

Cricut (NASDAQ:CRCT) Stock Rating Upgraded by Zacks Research

AtriCure, Inc. (NASDAQ:ATRC) Receives Average Rating of "Moderate Buy" from Analysts

AtriCure, Inc. (NASDAQ:ATRC) has received a "Moderate Buy" consensus rating from analysts, with an average 12-month price target of $48.50. The company recently reported strong quarterly results, exceeding EPS and revenue estimates, and provided positive fiscal year 2026 guidance. While institutional ownership is high …